RecruitingNCT04074538
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
The National Colorectal Cancer Cohort Study-Precision Medical Research in Colorectal Cancer
Sponsor
Ding Ke-Feng
Enrollment
55,000 participants
Start Date
Jan 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
NCRCC study is a national prospective cohort study including colorectal cancer screening population and stage Ⅰ-Ⅳ colorectal cancer patients.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Men and women
- Mentally/physically able to consent and participate
- Subjects aged ≥18 years old (Colorectal Cancer Patient Cohort, CRCPC), age 40-74 years (CRC Screening Cohort, CRCSC)
- Newly-diagnosed colon and rectal cancer for stages Ⅰ-Ⅳ (CRCPC)
Exclusion Criteria2
- A history of colorectal cancer or bowel resection
- Non-Chinese speaking
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04074538
Related Trials
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT0546403035 locations
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
NCT069922589 locations
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
NCT060775911 location
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT070717141 location
Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases
NCT064755601 location